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Abstract
Background: The classification of autosomal recessive ataxias represents a significant challenge because of high
genetic heterogeneity and complex phenotypes. We conducted a comprehensive systematic review of the
literature to examine all recessive ataxias in order to propose a new classification and properly circumscribe this
field as new technologies are emerging for comprehensive targeted gene testing.
Methods: We searched Pubmed and Embase to identify original articles on recessive forms of ataxia in humans for
which a causative gene had been identified. Reference lists and public databases, including OMIM and
GeneReviews, were also reviewed. We evaluated the clinical descriptions to determine if ataxia was a core feature
of the phenotype and assessed the available evidence on the genotype-phenotype association. Included disorders
were classified as primary recessive ataxias, as other complex movement or multisystem disorders with prominent
ataxia, or as disorders that may occasionally present with ataxia.
Results: After removal of duplicates, 2354 references were reviewed and assessed for inclusion. A total of 130
articles were completely reviewed and included in this qualitative analysis. The proposed new list of autosomal
recessive ataxias includes 45 gene-defined disorders for which ataxia is a core presenting feature. We propose a
clinical algorithm based on the associated symptoms.
Conclusion: We present a new classification for autosomal recessive ataxias that brings awareness to their complex
phenotypes while providing a unified categorization of this group of disorders. This review should assist in the
development of a consensus nomenclature useful in both clinical and research applications.
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Background
The classification of the hereditary ataxias has repre-
sented a challenge for decades due to the large hetero-
geneity of clinical presentations and the important
overlap between different pathologies [1]. The first to
propose a global classification for this group of disorders
was Greenfield in 1954, whose classification was based
on pathoanatomical findings [2]. This was followed by
Harding’s classification in 1983, which regrouped the
ataxias according to age of onset, as a proxy for mode of
inheritance, and clinical findings [3]. Although this clin-
ical classification had merit, it quickly became oversha-
dowed by a nomenclature based on gene discoveries
within each specific type of ataxia starting with ATXN1
in Spinocerebellar ataxia 1 in 1993 [4] and FXN in Frie-
dreich ataxia [5]. Since then, over 40 genes have been
discovered in the dominant ataxias and as many in re-
cessive ataxias [6].
One of the main challenges in the study of recessive
ataxias is the difficulty to properly circumscribe which dis-
orders belong to the field of hereditary ataxias and which
belong to other disease categories. Indeed, ataxia is a car-
dinal symptom in cerebellar disorders, but may also be a
presenting symptom of hereditary spastic paraplegias, her-
editary polyneuropathies, neurodevelopmental disorders,
and mitochondrial diseases, for example. Concurrently, re-
cessive ataxias often manifest with complex phenotypes,
even more so than their dominant counterparts, and may
present diverse associated features including neuropathy,
pyramidal and extrapyramidal involvement, oculomotor
* Correspondence: nicolas.dupre.cha@ssss.gouv.qc.ca
1Faculty of Medicine, Université Laval, Quebec city, QC G1V 0A6, Canada
4Department of Neurological Sciences, CHU de Quebec - Université Laval,
1401 18th street, Québec City, QC G1J 1Z4, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Beaudin et al. Cerebellum & Ataxias  (2017) 4:3 
DOI 10.1186/s40673-017-0061-y
abnormalities, cognitive involvement, seizures, retinop-
athy, hypogonadism, and many others. This explains the
high variability in the list of included disorders in recent
literature reviews on recessive ataxias [7, 8].
Nevertheless, the advent of next generation se-
quencing techniques requires to properly determine
which disorders belong to each disease category in
order to design thoughtful targeted panels and facili-
tate the interpretation of whole exome and whole
genome sequencing data. Indeed, targeted panel se-
quencing is a highly effective method for the diagno-
sis of neurological disorders, but it requires
insightful categorization of disease phenotypes to re-
spond to the specific needs of clinicians [9, 10].
Similarly, the interpretation of unknown variants in
the analysis of whole exome or whole genome se-
quencing data poses a significant challenge for clini-
cians who must determine if the gene is associated
with the suspected disease category and if the
phenotype correlates with what has previously been
described. As next generation sequencing techniques
become increasingly available and the ability to de-
tect DNA repeat expansion diseases improves [11],
the proper classification of diseases will represent a
useful tool in the interpretation of test results.
Hence, this calls for a systematic effort to review re-
cessive diseases in which ataxia is a prominent fea-
ture in order for experts in the field to collectively
determine which disorders should be included in a
recessive ataxia classification.
Therefore, the purpose of this article is to review the
literature on recessive diseases presenting with ataxia in
order to present a new classification. The goal is to bring
together experts for the development of a much-needed
consensus that fulfills research and clinical needs.
Methods
We conducted a systematic review to identify articles
relevant to the classification of autosomal recessive
ataxias. We searched Pubmed and Embase from incep-
tion to September 2016 in order to identify original arti-
cles on disorders presenting with ataxia. The search
strategy was large and targeted both recessive and spor-
adic ataxias, since recessive inheritance may appear
sporadic in certain circumstances (full search strategy is
provided in Additional file 1). We also reviewed refer-
ence lists of relevant articles and public databases in-
cluding OMIM and GeneReviews to identify other
relevant articles.
We reviewed the titles and abstracts of all identified
references to select original articles on recessive forms
of ataxia in humans for which a causative gene was iden-
tified. We evaluated the articles from a clinical perspec-
tive to determine if cerebellar ataxia was a prominent
feature in the reported patients or rather a secondary
finding in other movement or multisystem diseases. Dis-
eases reporting only on cerebellar atrophy or cerebellar
malformations without any clinical consequence were
not included. For each listed disorder, we reviewed the
evidence for a genotype-phenotype association using the
US National Human Genome Research Institute guide-
lines [12]. Major considerations included the exclusion
of previously described genes, the number of unrelated
individuals described with similar genotype-phenotype
correlations, the evidence of segregation with the dis-
ease, the absence of the variant in large control cohorts,
and the presence of biochemical or animal-model func-
tional validation. For the primary ataxias, we identified
two relevant references from different research groups
when possible. All relevant articles were fully reviewed
to be included in this classification of recessive ataxias.
Fig. 1 Flow diagram
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Table 1 Proposed new list of autosomal recessive ataxias
Disorder Gene OMIM Additional clinical features and neuroimaging findings Relevant
references
CTX CYP27A1 213700 Dementia, paresis, tendon xanthomas, atherosclerosis, cataracts, elevated cholestanol
level, childhood onset, variable cerebellar atrophy, cerebellar or cerebral
leukodystrophy
[17, 18]
AVED TTPA 277460 Retinitis pigmentosa, head titubation, low serum vitamin E, teenage onset, spinal
cord atrophy, absence of cerebellar atrophy
[19, 20]
AT ATM 208900 Telangiectasias, oculomotor apraxia, photosensitivity, immunodeficiency,
predisposition for cancer, elevation of α-foetoprotein, infantile onset, cerebellar
atrophy
[21, 22]
FRDA FXN 229300 Bilateral Babinski sign, square-wave jerks, scoliosis, hypertrophic cardiomyopathy,
sensory involvement, teenage onset, spinal cord atrophy, absence of cerebellar
atrophy
[5, 23]
ATLD MRE11 604391 Oculomotor apraxia, childhood onset, cerebellar atrophy [24, 25]
ARSACS SACS 270550 Spastic paraparesis, retinal striation, pes cavus, infantile or childhood onset, anterior
superior cerebellar atrophy, occasional T2-weighted linear hypointensities in pons
[26, 27]
AOA1/EAOH APTX 208920 Oculomotor apraxia, cognitive impairment, hypoalbuminemia, hypercholesterolemia,
childhood onset, cerebellar atrophy
[28, 29]
SCAN1 TDP1 607250 Peripheral axonal sensorimotor neuropathy, distal muscular atrophy,
hypercholesterolemia, teenage onset, cerebellar atrophy
[30, 31]
Cayman ataxia ATCAY 601238 Psychomotor retardation, hypotonia, strabism, neonatal onset, cerebellar hypoplasia [32, 33]
SANDO or MIRAS/SCAE POLG1 607459 In SANDO, sensory ataxia, ophtalmoparesis, myoclonus, ptosis, adult onset, variable
cerebellar atrophy, cerebellar white matter lesions, strokelike lesions. In MIRAS,
cerebellar and sensitive ataxia, epilepsy, migraine, myoclonus, childhood or teenage
onset, signal abnormalities in cerebellum and thalamus
[34, 35]
AOA2 SETX 606002 Polyneuropathy, pyramidal signs, oculomotor apraxia, head tremor, chorea, dystonia,
elevation of α-foetoprotein, teenage onset, cerebellar atrophy
[36, 37]
CAMRQ1, DES VLDLR 224050 Non-progressive cerebellar ataxia, mental retardation, hypotonia, strabismus,





C10orf2 271245 Athetosis, hypotonia, optic atrophy, ophtalmoplegia, hearing loss, epilepsy,
hypogonadism, liver involvement, infantile onset, moderate atrophy of brainstem
and cerebellum with advancing disease
[40, 41]
MSS SIL1 248800 Cataracts, mental retardation, myopathy, short stature, childhood onset, cerebellar
atrophy
[42, 43]
DCMA/MGCA5 DNAJC19 610198 Dilated cardiomyopathy, non-progressive cerebellar ataxia, mental retardation, tes-
ticular dysgenesis, anemia, increased urinary 3-methylglutaconic acid, infantile onset
[44, 45]





612016 Exercise intolerance, epilepsy, myoclonus, cognitive impairment, childhood onset,
cerebellar atrophy, occasional strokelike cerebral lesions
[48, 49]
SeSAME syndrome KCNJ10 612780 Epilepsy, sensorineural deafness, mental retardation, tubulopathy and electrolyte
imbalance, infantile onset, absence of cerebellar atrophy
[50, 51]
CAMRQ3 CA8 613227 Mild mental retardation, occasional quadrupedal gait, congenital onset, cerebellar
atrophy, white matter abnormalities
[52, 53]
Salih ataxia/SCAR15 (1 family) KIAA0226 615705 Epilepsy, mental retardation, childhood onset, absence of cerebellar atrophy [54, 55]
PHARC ABHD12 612674 Sensorimotor neuropathy, cataract, hearing loss, retinitis pigmentosa, teenage onset,
variable cerebellar atrophy
[56, 57]
SPAX4 (1 family) MTPAP 613672 Spastic paraparesis, optic atrophy, cognitive involvement, infantile onset [58, 59]
ARCA3 ANO10 613728 Cognitive impairment, downbeat nystagmus, teenage or adult onset, cerebellar
atrophy
[60, 61]
SCAR11 (1 family) SYT14 614229 Psychomotor retardation, late onset, cerebellar atrophy [62]
CAMRQ2 WDR81 610185 Occasional quadrupedal gait, cognitive impairment, congenital onset, hypoplasia of
cerebellum and corpus callosum
[63, 64]
AOA3 (1 family) PIK3R5 615217 Oculomotor apraxia, sensorimotor involvement, teenage onset, cerebellar atrophy [65]
Beaudin et al. Cerebellum & Ataxias  (2017) 4:3 Page 3 of 12
Identified disorders were classified in three categories:
the first included the primary autosomal recessive
ataxias, the second included other movement or multi-
system recessive diseases that have prominent ataxia,
and the final group was composed of recessive disorders
that may occasionally present with ataxia, but where
ataxia is a secondary feature.
We also developed a clinical algorithm for the primary
recessive ataxias based on the most frequent phenotype
and cardinal symptoms associated with each disorder.
The objective of this algorithm is to rapidly summarize
the main discriminatory features between different
ataxias to serve in a clinical setting, but also as a peda-
gogical and research tool.
Results
3750 references were identified through the literature
search in Pubmed and Embase, and 49 additional refer-
ences were identified through reference lists or public
databases. After removal of duplicates, 2354 references
Table 1 Proposed new list of autosomal recessive ataxias (Continued)
SCAR13 GRM1 614831 Cognitive impairment, mild pyramidal signs, short stature, seizures, congenital onset,
cerebellar atrophy
[66, 67]
CAMRQ4 (1 family) ATP8A2 615268 Cognitive impairment, occasional quadrupedal gait, congenital onset, cerebellar and
cerebral atrophy
[68]
SCAR7 (Allelic to CLN2) TPP1 609270 Pyramidal signs, posterior column involvement, tremor, childhood onset, atrophy of




RNF216 212840 Hypogonadotropic hypogonadism, dementia, occasional chorea, childhood to
young adult onset, cerebellar and cerebral atrophy
[71, 72]
SCAR18 GRID2 616204 Tonic upgaze, psychomotor retardation, retinal dystrophy, infantile onset, cerebellar
atrophy
[73, 74]
SCAR16 STUB1 615768 Pyramidal signs, neuropathy, occasional hypogonadism, variable age at onset,
cerebellar atrophy
[75, 76]
SCAR12 WWOX 614322 Tonic-clonic epilepsy, mental retardation, spasticity, neonatal to childhood onset,
variable cerebellar or cerebral atrophy
[77, 78]
ATLD2 (1 family) PCNA 615919 Telangiectasias, sensorineural hearing loss, photosensitivity, cognitive impairment,
short stature, childhood onset, cerebellar atrophy
[79]
SCAR20 SNX14 616354 Mental retardation, sensorineural hearing loss, macrocephaly, dysmorphism, infantile
onset, cerebellar atrophy
[80, 81]
SCAR17 CWF19L1 616127 Mental retardation, congenital onset, cerebellar hypoplasia [82, 83]
ACPHD (1 family) DNAJC3 616192 Diabetes mellitus, UMN signs, demyelinating neuropathy, sensorineural hearing loss,
childhood to adult onset, generalized supra- and infratentorial atrophy
[84]
LIKNS/SCAR19 (1 family) SLC9A1 616291 Sensorineural hearing loss, childhood onset, variable vermian atrophy [85]
AOA4 (Allelic to MCSZ) PNKP 616267 Dystonia, oculomotor apraxia, polyneuropathy, cognitive impairment, childhood
onset, cerebellar atrophy
[86, 87]
SCAR2 PMPCA 213200 Non-progressive cerebellar ataxia, cognitive impairment, pyramidal signs, short
stature, congenital or infantile onset, cerebellar atrophy
[88, 89]
SCAR21 SCYL1 616719 Liver failure, peripheral neuropathy, mild cognitive impairment, childhood onset,
cerebellar vermis atrophy, thinning of optic nerve
[90]
SCAR22 (1 family) VWA3B 616948 Cognitive impairment, pyramidal signs, adult onset, cerebellar atrophy and thin
corpus callosum
[91]
SCAR23 (1 family) TDP2 616949 Tonic seizures, cognitive impairment, dysmorphism, childhood onset [92]




THG1L - Psychomotor retardation, pyramidal signs, childhood onset, vermis hypoplasia [94]
ACPHD Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, AOA ataxia with oculomotor apraxia, ARCA autosomal recessive
cerebellar ataxia, ARSACS autosomal recessive spastic ataxia of Charlevoix-Saguenay, AT ataxia-telangiectasia, ATLD ataxia-telangiectasia-like disorder, AVED ataxia
with vitamin E deficiency, CA Cayman ataxia, CAMOS cerebellar ataxia mental retardation optic atrophy and skin abnormalities, CAMRQ cerebellar ataxia mental re-
tardation with or without quadrupedal locomotion, DCMA Dilated cardiomyopathy with ataxia, DES Desequilibrium syndrome, EAOH early-onset ataxia with oculo-
motor apraxia and hypoalbuminemia, FRDA Friedreich ataxia, IOSCA infantile onset spinocerebellar ataxia, LIKNS Lichtenstein-Knorr syndrome, MGCA5 3-
methyglutaconic aciduria type 5, MIRAS mitochondrial recessive ataxia syndrome, MCSZ Microchephaly seizures developmental delay, MSS Marinesco-Sjogren syn-
drome, MTDPS7 mitochondrial DNA depletion syndrome 7, PEOA3 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant
3, PHARC polyneuropathy hearing loss ataxia retinitis pigmentosa and cataract, SANDO sensory ataxic neuropathy with dysarthria and ophthalmoparesis, SCAE spi-
nocerebellar ataxia with epilepsy, SCAN1 spinocerebellar ataxia with axonal neuropathy 1, SCAR Spinocerebellar ataxia, autosomal recessive, SeSAME Seizures sen-
sorineural deafness ataxia mental retardation and electrolyte imbalance, SPAX spastic ataxia, UMN upper motor neuron
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Table 2 Other complex movement or multisystem recessive disorders that have prominent ataxia
Disorder Gene OMIM Clinical features and imaging findings Comment References
Abetalipoproteinemia MTTP 200100 Fat malabsorption symptoms, hypocholesterolemia,
hypotriglyceridemia, acanthocytosis, Friedreich-like ataxia, neo-
natal onset, absence of cerebellar atrophy
Multisystem [95]
Nieman Pick type C NPC1 257220 Vertical supranuclear ophtalmoplegia, ataxia, splenomegaly,
childhood to adult onset, variable cerebellar or cerebral atrophy
Multisystem [96, 97]
NPC2 607625
Refsum disease PAHX 266500 Retinitis pigmentosa, polyneuropathy, ataxia, increased CSF
protein, anosmia, deafness, ichtyosis, teenage onset, elevated









Ataxia, dysarthria, intellectual impairment, extrapyramidal signs,




SPARCA1 SPTBN2 615386 Ataxia, cognitive impairment, eye-movement abnormalities, early
childhood onset, cerebellar atrophy
Allelic to SCA5 [9, 103]
SPAX5 AFG3L2 614487 Ataxia, spasticity, oculomotor apraxia, myoclonic epilepsy,
neuropathy, dystonia, optic atrophy, childhood onset, cerebellar
atrophy




PNPLA6 215470 Ataxia, hypogonadotropic hypogonadism, chorioretinal
dystrophy or brisk reflexes, childhood onset, atrophy of
cerebellum and pons
Allelic to HSP39 [106, 107]
Gillespie syndrome ITPR1 206700 Non-progressive cerebellar ataxia, iris hypoplasia, cognitive
impairment, neonatal onset, progressive cerebellar atrophy
Allelic to SCA15/29 [108]
SPAX2/SPG58 KIF1C 611302 Spastic paraparesis, cerebellar ataxia, childhood or teenage




SPG7 SPG7 607259 Spasticity, pyramidal signs, cerebellar signs, optic neuropathy,
ptosis, teenage or adult onset, cerebellar atrophy
HSP [111, 112]
SPG5 CYP7B1 270800 Spasticity, cerebellar and sensory ataxia, childhood or teenage
onset, white matter lesions
HSP [113, 114]
SPG11 KIAA1840 604360 Spasticity, ataxia, cognitive impairment, sensorimotor
neuropathy, childhood or teenage onset, thin corpus callosum,
signal abnormalities in cervical cord
HSP [115, 116]
SPG46 GBA2 614409 Cerebellar ataxia, spastic dysarthria, mild cognitive impairment,
hearing loss, cataracts, childhood onset, cerebellar and cerebral




PMM2 212065 Psychomotor retardation, axial hypotonia, abnormal eye





LBSL DARS2 611105 Cerebellar ataxia, tremor, spasticity, dorsal column dysfunction,
axonal neuropathy, childhood to adult onset, signal
abnormalities in cerebral white matter and specific brainstem




COX20 220110 Cerebellar ataxia, dystonia, sensory axonal neuropathy, variable,




Aceruloplas-minemia CP 604290 Diabetes, dementia, movement disorder, cerebellar ataxia, retinal
degeneration, late onset, decreased signal intensity in thalamus,





PLA2G6 256600 Cerebellar ataxia, psychomotor retardation, psychiatric features,
axonal sensorimotor neuropathy, infantile or teenage onset,








LAMA1 615960 Nonprogressive ataxia, oculomotor ataxia, psychomotor




FLVCR1 609033 Posterior column degeneration and retinitis pigmentosa,
childhood onset, signal abnormalities in cervical spinal cord
Sensory ataxia [128, 129]
HSP hereditary spastic paraplegia, LBSL leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation, SPARCA1 spectrin-associated auto-
somal recessive cerebellar ataxia type 1, SPAX spastic ataxia, SPG spastic paraplegia
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were reviewed on the basis of title and abstract. Finally,
130 articles were selected on the basis of the aforemen-
tioned criteria and completely reviewed to be included
in this qualitative analysis (Fig. 1).
The proposed new list of autosomal recessive ataxias
is presented in Table 1 in chronological order of gene
discovery. The disorders included in this list were evalu-
ated as having a relatively predominant cerebellar in-
volvement compared to the involvement of other
neurologic and non-neurologic systems. Table 2 presents
the other complex motor or multisystem disorders that
have prominent ataxia. Finally, Table 3 presents disor-
ders that may occasionally present with ataxia, but
where ataxia is a secondary feature. Certain decisions
were made in the elaboration of this classification. Not-
ably, abetalipoproteinemia (ABL) and Refsum disease
were not included in the list of primary recessive ataxias,
but rather in the list of complex disorders that have
prominent ataxia. Indeed, despite their important
Friedreich-like neurological picture, these disorders are
primary lipid metabolism disorders with multisystem in-
volvement. Moreover, ataxic disorders that are allelic to
other movement disorders, especially spinocerebellar
ataxias and hereditary spastic paraplegias, were assigned
to the second category to avoid any confusion with the
primary recessive ataxias. The MARS2-linked autosomal
recessive ataxia with leukoencephalopathy (ARSAL/
SPAX3) was not included because the genetic evidence
was deemed insufficient [13]. Finally, some disorders de-
scribed only in single families were included, despite this
being a factor for weaker genetic evidence, if other major
considerations were met; this was indicated in the list.
The primary recessive ataxias were also organized in a
clinical algorithm (Fig. 2) according to the presence of
key clinical clues, which include the presence of sensori-
motor involvement, cognitive impairment, spasticity,
and oculomotor abnormalities.
Other disorders have been reported with ataxia, but
the authors evaluated that these disorders did not need
to be included in the differential diagnosis of recessive
ataxias. However, clinicians may bear in mind that the
following may have ataxia as an associated feature:
Lafora disease (EPM2A, EPM2B), megalencephalic leu-
koencephalopathy with subcortical cysts (MLC1),
COL18A1-linked ataxia epilepsy cognitive problems and
visual problems, Perrault syndrome (HSD17B4),
Zellweger-spectrum disorders (PEX2), Wolfram syn-
drome (WFS1), Canavan disease (ASPA), metachromatic
leukodystrophy (ARSA), Galloway-Mowat syndrome
(WDR73), and GLUT-1 deficiency (SCL2A1).
Discussion
We present a new classification for the autosomal reces-
sive ataxias. This classification should allow for better
Table 3 Recessive disorders that may occasionally present with ataxia, but where ataxia is a secondary feature
Disorder Gene OMIM Clinical features and imaging findings Comment References
Neuronal ceroid lipofuscinoses CLN5 CLN6 256731
601780
Psychomotor retardation, visual failure, seizures,
childhood to teenage onset, cerebellar and cerebral
atrophy
Ataxia is a rare
feature
[130, 131]




Hypotonia, cerebellar ataxia and mental retardation,









Many Ataxia, hypotonia, neonatal breathing abnormalities,
mental retardation, nephronophtisis, congenital onset,






Hartnup disorder SLC6A19 234500 Transient manifestations of pellagra, cerebellar ataxia and




Childhood ataxia with central
nervous system hypomyelination/
vanishing white matter disease
elF2B 603896 Cerebellar ataxia with spasticity. Rapid deterioration
following head trauma or febrile illness, infantile to adult
onset, diffusely abnormal cerebral white matter
Leukodystrophy [137, 138]
L-2-Hydroxyglutaric aciduria L2HGDH 236792 Psychomotor retardation, epilepsy, macrocephaly,
cerebellar ataxia, infantile onset, subcortical






GOSR2 614018 Ataxia, myoclonic epilepsy, raised creatine kinase, early






POLR3A 607694 Tremor, cerebellar ataxia, cognitive regression, UMN signs,
childhood onset, hypomyelination of deep white matter,
cerebellar atrophy, thin corpus callosum
Leukodystrophy [142]
Recessive Behr’s syndrome OPA1 210000 Optic atrophy, ataxia, peripheral neuropathy, digestive
symptoms, infantile or childhood onset, cerebellar
atrophy
Optic atrophy [143, 144]
ISSD infantile sialic acid storage disease
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categorization of recessive disorders presenting with
ataxia with a clear separation between the primary reces-
sive ataxias and disorders that may present with ataxia
as an associated feature but belong to other disease cat-
egories. We also provided a clinical algorithm as a tool
for diagnostic, learning, and research purposes. This
comprehensive classification will allow for improved
genetic diagnosis by targeted next generation sequencing
applications as the ability to detect DNA repeat expan-
sion diseases is quickly becoming a reality with pros-
pects of treatment in the future [11, 14, 15].
As compared to previously published reports on this
subject [7, 8], we systematically reviewed the literature
to evaluate the available evidence on the disease-
associated genes in order to include all disorders pre-
senting with a predominant cerebellar ataxia phenotype.
The systematic review methodology with a structured
data search and comprehensive evaluation of all refer-
ences allowed for a complete evaluation of the literature
regarding disorders presenting with ataxia to ensure that
all potentially relevant disorders were included in this
classification. Nevertheless, some methodological ele-
ments were not applicable to the task at hand. For ex-
ample, two references were selected for each primary
recessive ataxia, and articles that provided evidence for a
separate genetic basis with a clinical corollary of ataxia
were preferred. Therefore, some articles that provided
only detailed clinical description were not included.
Moreover, inclusion criteria were clearly defined but
there remained a place for interpretation to determine if
cerebellar ataxia was a core feature of the phenotype and
if the genotype-phenotype association was convincing.
Thus, the classification of individual disorders between
the three groups, i.e. as a recessive ataxia, a complex dis-
order with predominant ataxia or a disorder where
ataxia is a secondary feature, remains a subjective appre-
ciation and is open for discussion by a dedicated task
force in order to reach a consensus. Finally, the search
Fig. 2 Clinical algorithm of autosomal recessive ataxias
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strategy was designed to be as sensible as possible, but
ataxia is a frequent symptom in neurology, and it is pos-
sible that other ataxia-associated disorders could be con-
sidered for inclusion.
Important challenges remain to be addressed. First,
the nosology of recessive ataxias is still highly confusing.
Contrary to the dominantly inherited spinocerebellar
ataxias, no universal acronym was adopted in the field of
recessive ataxias, such that disorders were named based
on the author who first described them, on regions of
high prevalence, or according to clinical presentation. In
the last few years, the term spinocerebellar ataxia, auto-
somal recessive (SCAR) was used to designate novel re-
cessive ataxias, but this nomenclature did not include
the previously described and most frequent ataxias.
Moreover, as SCAR assignation was based on locus dis-
covery, some of the included SCARs do not correspond
to an identified gene. The term SPAX has also been used
to designate ataxias with a strong spasticity component,
irrespectively of their mode of inheritance. Recently, the
International Parkinson and Movement Disorder Society
Task Force for Nomenclature of Genetic Movement Dis-
orders recommended a nomenclature with a gene suffix
in order to overcome the shortcomings of the numbered
locus system, which include erroneously assigned loci,
the mingling of causative and risk factor genes, uncon-
firmed causative associations, and inconsistent pheno-
typic correlations [16]. These concerns are justified,
although numbered naming systems present definite ad-
vantages for ease of use and proper delineation of the
field. The nomenclature of recessive ataxias should be
discussed by a dedicated task force of international ex-
perts in order to develop a naming system that reflects
the complexity of the recessive ataxia phenotypes while
allowing convenient clinical use.
Finally, large phenotypic variability exists between pa-
tients from different families and even from a single
family with the same mutated gene, depending on the
type of mutation and on its location in the gene. Other
factors that affect age at onset and clinical course prob-
ably include the presence of modifier genes and environ-
mental exposures. Hence, one could argue that the
paradigm of one gene-one disease presented here does
not reflect all the phenotypic variability observed, and
could as well be replaced by the concept of one patient-
one disease as we identify new genetic and environmen-
tal prognostic features that characterise more precisely
the age at onset, evolution, and response to treatment.
Such developments are likely to modify our understand-
ing of genetic disorders and of their classification.
Conclusion
We present herein a classification of the autosomal re-
cessive ataxias based on a systematic review of the
literature. This work should serve as a framework for
scientific discussion in order to bring together experts
for the establishment of a much-needed consensus in
this field.
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